229 related articles for article (PubMed ID: 35421660)
1. Anticancer activity of ruthenium(II) plumbagin complexes with polypyridyl as ancillary ligands via inhibiting energy metabolism and GADD45A-mediated cell cycle arrest.
Li YL; Zhu XM; Chen NF; Chen ST; Yang Y; Liang H; Chen ZF
Eur J Med Chem; 2022 Jun; 236():114312. PubMed ID: 35421660
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, RNA-sequence and evaluation of anticancer efficacy of ruthenium(II) polypyridyl complexes toward HepG2 cells.
Hu H; Zhang H; Zhong R; Yang Y; Huang C; Chen J; Liang L; Chen Y; Liu Y
J Inorg Biochem; 2023 Jul; 244():112230. PubMed ID: 37084581
[TBL] [Abstract][Full Text] [Related]
3. Lysosome-targeted ruthenium(II) complexes induce both apoptosis and autophagy in HeLa cells.
Pan NL; Liao JX; Huang MY; Zhang YQ; Chen JX; Zhang ZW; Yang ZX; Long XE; Wu XT; Sun J
J Inorg Biochem; 2022 Apr; 229():111729. PubMed ID: 35066350
[TBL] [Abstract][Full Text] [Related]
4. Cyclometalated Ru(II)-NHC complexes with phenanthroline ligands induce apoptosis mediated by mitochondria and endoplasmic reticulum stress in cancer cells.
Chen C; Lv H; Xu H; Zhu D; Shen C
Dalton Trans; 2023 Feb; 52(6):1671-1679. PubMed ID: 36648504
[TBL] [Abstract][Full Text] [Related]
5. Novel cyclometalated Ru(II) complexes containing isoquinoline ligands: Synthesis, characterization, cellular uptake and in vitro cytotoxicity.
Chen J; Wang J; Deng Y; Li B; Li C; Lin Y; Yang D; Zhang H; Chen L; Wang T
Eur J Med Chem; 2020 Oct; 203():112562. PubMed ID: 32698112
[TBL] [Abstract][Full Text] [Related]
6. Green Light-Triggered Photocatalytic Anticancer Activity of Terpyridine-Based Ru(II) Photocatalysts.
Mandal AA; Singh V; Saha S; Peters S; Sadhukhan T; Kushwaha R; Yadav AK; Mandal A; Upadhyay A; Bera A; Dutta A; Koch B; Banerjee S
Inorg Chem; 2024 Apr; 63(16):7493-7503. PubMed ID: 38578920
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and anticancer evaluation of novel half-sandwich Ru(II) complexes bearing pyrazalone moiety: Apoptosis inducers based on mitochondrial dysfunction and G0/G1 arrest.
Huang Y; Huang S; Wei W; Wu Y; Jia L; Du Y; Luo P; Pan W
J Inorg Biochem; 2024 Jan; 250():112421. PubMed ID: 37922609
[TBL] [Abstract][Full Text] [Related]
8. Anti-metastasis and anti-proliferation effect of mitochondria-accumulating ruthenium(II) complexes via redox homeostasis disturbance and energy depletion.
Xie L; Wang L; Guan R; Ji L; Chao H
J Inorg Biochem; 2021 Apr; 217():111380. PubMed ID: 33578250
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of ruthenium complexes bearing the 1,2,4-triazole group as potential membrane-targeting antibacterial agents towards
Wang P; Huang HY; Dou LX; Deng W; Wang JT; Liao XW; Yu RJ; Duan XM; Xiong YS
Dalton Trans; 2023 Jun; 52(25):8737-8746. PubMed ID: 37313713
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization and biological evaluation of labile intercalative ruthenium(ii) complexes for anticancer drug screening.
Huang H; Zhang P; Chen Y; Qiu K; Jin C; Ji L; Chao H
Dalton Trans; 2016 Aug; 45(33):13135-45. PubMed ID: 27294337
[TBL] [Abstract][Full Text] [Related]
11. Visible-Light-Responsive Novel Ru(II)-Metallo-Antibiotics with Potential Antibiofilm and Antibacterial Activity.
Mandal AA; Upadhyay A; Mandal A; Nayak M; K MS; Mukherjee S; Banerjee S
ACS Appl Mater Interfaces; 2024 May; ():. PubMed ID: 38783713
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, anticancer and antibacterial activity of some novel mononuclear Ru(II) complexes.
Mazumder UK; Gupta M; Karki SS; Bhattacharya S; Rathinasamy S; Thangavel S
Chem Pharm Bull (Tokyo); 2004 Feb; 52(2):178-85. PubMed ID: 14758001
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization, and anticancer activity of ruthenium(II)-β-carboline complex.
Chen Y; Qin MY; Wu JH; Wang L; Chao H; Ji LN; Xu AL
Eur J Med Chem; 2013; 70():120-9. PubMed ID: 24141202
[TBL] [Abstract][Full Text] [Related]
14. Systematic evaluation of the antitumor activity of three ruthenium polypyridyl complexes.
Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
J Inorg Biochem; 2021 Dec; 225():111616. PubMed ID: 34555601
[TBL] [Abstract][Full Text] [Related]
15. [Ru(phen)
Li R; Ma Y; Hu X; Wu W; Wu X; Dong C; Shi S; Lin Y
Dalton Trans; 2020 Jul; 49(26):8864-8871. PubMed ID: 32602487
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of four novel nitrogen-heterocyclic ruthenium polypyridyl complexes as photosensitizers for one and two-photon photodynamic therapy.
Kou J; Shen J; Lin M; Xiong K; Wang L; Wei F; Zhang J
Dalton Trans; 2023 May; 52(21):6978-6986. PubMed ID: 37067849
[TBL] [Abstract][Full Text] [Related]
17. Significant increase of anticancer efficacy in vitro and in vivo of liposome entrapped ruthenium(II) polypyridyl complexes.
Chen Y; Li W; Yang Y; Zhong R; Hu H; Huang C; Chen J; Liang L; Liu Y
Eur J Med Chem; 2023 Sep; 257():115541. PubMed ID: 37295162
[TBL] [Abstract][Full Text] [Related]
18. Novel polypyridyl ruthenium complexes acting as high affinity DNA intercalators, potent transcription inhibitors and antitumor reagents.
Ma GL; Bi XD; Gao F; Feng Z; Zhao DC; Lin FJ; Yan R; Liu D; Liu P; Chen J; Zhang H
J Inorg Biochem; 2018 Aug; 185():1-9. PubMed ID: 29730231
[TBL] [Abstract][Full Text] [Related]
19. New ruthenium polypyridyl complexes functionalized with fluorine atom or furan: Synthesis, DNA-binding, cytotoxicity and antitumor mechanism studies.
Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
Spectrochim Acta A Mol Biomol Spectrosc; 2020 Feb; 227():117534. PubMed ID: 31685424
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, characterization and antitumor mechanism investigation of ruthenium(II) polypyridyl complexes with artesunate moiety.
Chen BC; Lu JJ; Jiang N; Ma XR; Li RT; Ye RR
J Biol Inorg Chem; 2021 Dec; 26(8):909-918. PubMed ID: 34545414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
